Font Size: a A A
Keyword [Cytokine release syndrome]
Result: 1 - 16 | Page: 1 of 1
1. Clinical And Mechanistic Study Of CD123-Targeted CAR-T In The Treatment Of AML
2. New Strategies To Improve The Safety And Efficacy Of CART In Hematological Malignancies
3. A Novel Split CAR-T Targeting Glypican-3 In Anti-hepatocellular Carcinoma:The Roles And Mechanisms
4. Construction And Application Of Nursing Program For Cytokine Release Syndrome In Patients With Hematologic Malignancies Treated By Chimeric Antigen Receptor T Cells
5. Preliminary Study On The Safety And Efficacy Of Chimeric Antigen Receptor T Cell Therapy In Elderly Patients With Hematologic Malignancies
6. Basic And Clinical Study On CD19-CAR-T Cells For B Cell Non-hodgkin Lymphoma
7. Treatment Of Relapsed And Refractory Acute Myeloid Leukemia (MDs Transformation) With CD123 Chimeric Antigen Receptor T Cell And Literature Review
8. A Single-center,Open,One-arm Clinical Study Of The Safety And Efficacy Of Infusion Of Anti-BCMA CAR-T For Relapsed/Refractory/High-risk BCMA+ Tumors
9. Prediction And Control Strategy Of Cytokine Release Syndrome After CAR-T Treatment
10. Changes Of Cytokine Levels After Relapsed/refractory B-ALL Treated With CD19 CAR-T Cells And Its Clinical Significance
11. The Efficacy And Safety Of Chimeric Antigen Receptor T Cells In The Treatment Of Relapsed/refractory B-cell Acute Lymphoblastic Leukemia
12. Improved Radiotherapy Segmentation Combined With CAR-T Cell For B Cell Lymphoma
13. Gasdermin E-mediated Target Cell Pyroptosis By CAR T Cells Triggers Cytokine Release Syndrome
14. Toxicities And Relative Factors Of CD19 Targeted Chimeric Antigen Receptor T Cell Therapy In Relapse/refractory B-cell Hematological Malignancies
15. Clinical Study Of Targeting CD19 Fourth-generation Chimeric Antigen Receptor T Cells In Treating Relapsed Or Refractory B Cell Non-hodgkin Lymphoma
16. Clinical Analysis Of BCMA CAR-T Cells In The Treatment Of Relapsed And Refractory Multiple Myeloma Patients
  <<First  <Prev  Next>  Last>>  Jump to